Most human tissue products are derived from cadavers and processed by third-party tissue banks. BioD’s placental-derived allografts are recovered from live, healthy donors that we pre-screen during pregnancy and select based on our stringent donor selection criteria. From aseptic recovery of the tissue at childbirth to timely processing of our allografts, our protocols and procedures have been developed to meet or exceed all applicable industry standards for the use of human cellular and tissue-based products. Our operating entities are registered with the FDA and accredited by the American Association of Tissue Banks. At BioD, we believe the use of live, healthy donors is a better approach to regenerative medicine.